Palbociclib improves progression-free survival in HER2 positive breast cancer

Post author:admin
Post published:January 30, 2026
Post category:uncategorized

PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England Journal of Medicine (NEJM).

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Importance of clear numerical communication in medicine

How body image perceptions shape health habits in young fitness enthusiasts

Swapping red meat for plant-based meat rapidly lowers a key heart risk metabolite, trial finds

Helpful Links

Subscribe To Us